Sponsored in conjunction with the American Medical Writers Association (AMWA), featuring Nancy Smith, PhD, RACI, SVP, Medical Writing Services, and Jennifer Kilroy, PhD, MBA, SVP, Head of Strategy & Transformation at Syner-G
AI is changing how teams approach medical writing and content development across drug development. Teams now use AI to support drafting, review, and content reuse. These advances can improve efficiency and consistency while raising important questions about quality, oversight, and scientific integrity.
This webinar explores how organizations apply AI within medical writing workflows today. The session focuses on practical, real-world use cases. Weave will demonstrate how AI can support drafting, streamline review cycles, and improve content reuse. The platform helps teams maintain control, traceability, and submission-ready quality throughout the process.
Syner-G BioPharma Group will discuss what organizations must change to support long-term adoption. As a strategic development and delivery partner, Syner-G provides CMC, regulatory, and scientific consulting services. Their session will focus on roles, responsibilities, and governance models that support consistency and accountability when using AI.
Together, the speakers will share a practical view of how organizations can move from experimentation to scalable impact while keeping medical writers central to the process.